Related Experiment Videos
Raf and mitogen-activated protein kinase regulate stellate cell collagen gene expression
1Department of Medicine, University of Chicago Medical Center, Illinois 60637, USA. bhdavis@medicine.bsd.uchicago.edu
The Journal of Biological Chemistry
|May 10, 1996
Summary
Activated hepatic stellate cells drive liver fibrosis by dysregulating collagen gene expression. A novel protein, p60, interacts with Raf kinases, suggesting a new pathway in liver injury and cirrhosis development.
Area of Science:
- Cell biology
- Molecular biology
- Hepatology
Background:
- Hepatic stellate cells (HSCs) activate into myofibroblasts during liver injury, a key step in fibrogenesis.
- Dysregulated collagen gene expression in HSCs is central to cirrhosis development.
- The Raf and mitogen-activated protein (MAPK) kinase pathways are implicated in HSC collagen gene regulation.
Purpose of the Study:
- To investigate the differential regulation of alpha I(II) collagen gene expression by Raf and MAPK pathways in activated HSCs.
- To identify signaling pathways and regulatory elements involved in HSC activation and fibrogenesis.
Main Methods:
- Analysis of collagen gene regulation in activated hepatic stellate cells.
- Mapping of stimulatory and inhibitory signaling pathways to specific DNA binding domains.
- Identification and characterization of a novel DNA-binding protein (p60).
Main Results:
- Raf and MAPK kinases differentially regulate alpha I(II) collagen gene expression in activated HSCs, indicating a signaling branch point.
- A MAPK-stimulatory signal converges on NF-1 and Sp-1 binding domains in the collagen gene's 5'-untranslated region.
- A Raf-inhibitory signal involves a novel 60-kDa DNA-binding protein (p60) binding upstream.
- p60 is expressed and induced in HSCs during early hepatic fibrogenesis in vivo.
Conclusions:
- A novel Raf-p60 signaling pathway plays a crucial role in regulating collagen gene expression in activated HSCs.
- This pathway is specifically induced during early hepatic fibrogenesis, highlighting its importance in liver injury.
- Targeting the p60 pathway may offer a therapeutic strategy for liver fibrosis and cirrhosis.